https://www.nasdaq.com/press-release/aspira-womens-health-executes-an-agreement-with-axia-womens-health-to-launch-aspira
https://www.nasdaq.com/press-release/aspira-womens-health-announces-fourth-quarter-operational-metrics-and-provides
https://www.nasdaq.com/press-release/aspira-womens-health-appoints-minh-merchant-as-general-counsel-2022-01-05
https://www.nasdaq.com/press-release/aspira-womens-health-reports-third-quarter-2021-financial-results-2021-11-10
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-to-report-third-quarter-2021-financial-results-on-november
https://www.nasdaq.com/press-release/genoox-and-aspira-womens-health-inc.-partner-to-develop-and-deliver-data-driven
https://www.nasdaq.com/press-release/aspira-womens-health-black-womens-health-imperative-lead-congressional-briefing-2021
https://www.nasdaq.com/press-release/aspira-womens-health-executes-four-aspira-synergytm-technology-transfer-agreements
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-to-present-at-the-cantor-fitzgerald-virtual-global
https://www.nasdaq.com/press-release/aspira-womens-health-kicks-off-ovarian-cancer-awareness-month-by-further-establishing
https://www.nasdaq.com/press-release/aspira-womens-health-reports-second-quarter-2021-financial-results-2021-08-12
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-to-report-second-quarter-2021-financial-results-on-august
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-announces-coverage-for-ova1r-in-the-aim-specialty-health
https://www.nasdaq.com/press-release/aspira-womens-health-releases-analytical-and-initial-clinical-validation-performance
https://www.nasdaq.com/press-release/35-of-the-best-ideas-companies-to-present-at-the-summer-solstice-best-ideas-from-the
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-to-participate-in-the-william-blair-growth-stock-conference
https://www.nasdaq.com/press-release/aspira-womens-health-reports-first-quarter-2021-financial-results-2021-05-13
https://www.nasdaq.com/press-release/aspira-womens-health-to-reveal-3rd-generation-ovarian-cancer-risk-assessment
https://www.nasdaq.com/press-release/aspira-womens-health-initiates-prospective-clinical-study-for-benign-risk-monitoring
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-expands-leadership-team-with-industry-veteran-2021-05-11
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-to-report-first-quarter-2021-financial-results-on-may-13
https://www.nasdaq.com/press-release/aspira-womens-health-reports-fourth-quarter-and-full-year-2020-financial-results-2021
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-announces-an-agreement-for-the-development-and
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-to-report-fourth-quarter-and-full-year-2020-financial
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-announcement-new-york-state-medicaid-now-considers-ova1r
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-appoints-nicole-sandford-to-its-board-of-directors-2021-02
https://www.nasdaq.com/press-release/aspira-womens-health-recognizes-the-importance-of-bridging-the-gap-in-ovarian-cancer
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-to-participate-in-btigs-virtual-medtech-digital-health-life
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-to-add-nccn-management-recommendations-to-its-proprietary
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-announces-pricing-of-%2445-million-public-offering-of-common
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-announces-proposed-public-offering-of-common-stock-2021-02
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-announces-it-is-now-a-highmark-contracted-provider-in
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-to-participate-in-virtual-investor-events-2021-01-04
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-announces-a-collaborative-agreement-with-baylor-genetics
https://www.nasdaq.com/press-release/aspira-womens-health-reports-third-quarter-2020-financial-results-2020-11-12
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-strengthens-executive-leadership-with-new-appointments-2020
https://www.nasdaq.com/press-release/aspira-womens-health-strengthens-board-of-directors-with-the-addition-of-dr.-sandra-e
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-to-present-at-the-canaccord-genuity-virtual-medtech
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-to-report-third-quarter-2020-financial-results-on-november
https://www.nasdaq.com/press-release/aspira-womens-health-addresses-clinical-disparities-in-ovarian-cancer-risk-assessment
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-announces-it-is-now-an-anthem-bluecross-blueshield-of
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-to-present-at-microcap-rodeo-best-ideas-bowl-october-13-16
https://www.nasdaq.com/press-release/the-microcap-rodeo-best-ideas-bowl-2020-october-13-16-2020-2020-10-08
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-to-host-key-opinion-leader-call-on-ovarian-cancer
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-to-present-at-cantor-virtual-healthcare-conference-2020-09
https://www.nasdaq.com/press-release/aspira-womens-health-reports-second-quarter-2020-financial-results-2020-08-13
https://www.nasdaq.com/press-release/aspira-womens-health-inc.-to-report-second-quarter-2020-financial-results-on-august
https://www.nasdaq.com/press-release/vermillion-completes-validation-of-new-pre-surgical-test-offerings-with-ova1rplus
https://www.nasdaq.com/press-release/vermillion-set-to-join-russell-3000r-index-2020-06-09
https://www.nasdaq.com/press-release/vermillion-reports-first-quarter-2020-financial-results-2020-05-14
https://www.nasdaq.com/press-release/vermillion-to-report-first-quarter-2020-financial-results-on-may-14-2020-04-30
https://www.nasdaq.com/press-release/vermillion-inc.-announces-aspira-labs-now-credentialed-as-florida-state-medicaid
https://www.nasdaq.com/press-release/vermillion-announces-cigna-preferred-contract-coverage-for-ova1-overa-and-genetics
https://www.nasdaq.com/press-release/vermillion-reports-fourth-quarter-2019-financial-results-2020-03-26
https://www.nasdaq.com/press-release/vermillion-to-participate-in-statewide-women-and-girls-day-at-the-connecticut-state
https://www.nasdaq.com/press-release/vermillion-to-report-fourth-quarter-2019-financial-results-on-march-26-2020-03-03
https://www.nasdaq.com/press-release/vermillion-to-participate-at-the-32nd-annual-roth-conference-2020-02-25
https://www.nasdaq.com/press-release/vermillion-to-present-at-2020-biotech-showcase-participate-in-lifesci-advisors
https://www.nasdaq.com/press-release/vermillion-inc.-and-einstein-medical-center-philadelphia-announce-the-first-patient
https://www.nasdaq.com/press-release/vermillion-to-participate-at-the-piper-jaffray-31st-annual-healthcare-conference-2019
https://www.nasdaq.com/press-release/vermillion-reports-third-quarter-2019-financial-results-2019-11-12
https://www.nasdaq.com/press-release/vermillion-to-report-third-quarter-2019-financial-results-on-november-12-2019-10-08
https://www.nasdaq.com/press-release/vermillion-to-participate-at-2019-cantor-global-healthcare-conference-2019-09-30
https://www.nasdaq.com/press-release/vermillion-report-fourth-quarter-and-year-end-2018-financial-results-thursday-march
